The first step towards personalized medicine in IBD
A simple, CE-marked, whole blood test, providing long-term prognostic data that can guide clinical management in inflammatory bowel disease (Crohn’s disease and ulcerative colitis).
Award-winning PredictSURE IBD™ is the world’s first validated and CE-marked prognostic test for guiding treatment options in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). PredictSURE IBD™ is based upon 10 years of extensive research on gene expression profiling of CD8+ T cells. This whole blood-based biomarker test is a major step towards personalized medicine in IBD.
PredictSURE IBD™ is a biomarker test combined with a sophisticated, proprietary algorithm that will tell you the likely course of your newly diagnosed patients’ IBD; differentiating between an aggressive or milder form of the disease. All you need is a small blood sample from your patients (16+ years) and an on-line account for rapid, on-line reporting. With PredictSURE IBD™ you can take control of Crohn’s disease and ulcerative colitis treatment options.